Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
Conditions: MDS; Immunodeficiency; GATA2
Interventions: Drug: Cyclophosphamide (CTX, Cytoxan); Drug: Fludarabine(Fludara,Berlex Laboratories); Procedure: Total Body Irradiation (TBI); Procedure: Allogeneic HSC; Drug: Equine Anti-Thymocyte Globulin
Sponsor: National Cancer Institute (NCI)
Active, not recruiting - verified September 23, 2016
Interventions: Drug: Cyclophosphamide (CTX, Cytoxan); Drug: Fludarabine(Fludara,Berlex Laboratories); Procedure: Total Body Irradiation (TBI); Procedure: Allogeneic HSC; Drug: Equine Anti-Thymocyte Globulin
Sponsor: National Cancer Institute (NCI)
Active, not recruiting - verified September 23, 2016